Table 2.
Comparison between hematological variables of patients in four stages of breast cancer by ANOVA
| Variable | Stage I | Stage II | Stage III | Stage IV | P-value |
|---|---|---|---|---|---|
| WBC(µL-1) | 3.22±0.89 | 5.29±1.30 | 5.63±1.93 | 6.30±1.50 | 0.030 |
| RBC(µL-1) | 4.10±0.21 | 3.93±0.43 | 3.94±0.38 | 4.30±0.62 | 0.277 |
| HGB(g/dL) | 11.5±0.3 | 10.9±1.1 | 10.5±0.9 | 10.7±1.7 | 0.360 |
| HCT(g/dL) | 35.9±0.5 | 34.5±2.9 | 33.8±2.3 | 38.2±6.3 | 0.051 |
| MCV(fL) | 87.1±5.6 | 88.3±4.9 | 86.1±5.8 | 88.1±9.7 | 0.607 |
| MCH(pg) | 28±1.9 | 27.8±1.3 | 26.7±2.2 | 24.9±4.5 | 0.039 |
| MCHC(g/dL) | 31.8±0.9 | 31.4±1.1 | 31±1.5 | 28.7±6.6 | 0.077 |
| PLT(µL-1) | 247.5±75 | 253.5±49.9 | 254.3±52.2 | 242.7±82.7 | 0.978 |
| Lym% | 35.5±9 | 30.4±7.7 | 30±9.5 | 27.5±5.2 | 0.580 |
Abbreviations; WBC: white blood cells, RBC: red blood cells, HGB: hemoglobin, HTC: hematocrit, MCV: mean cell volume, MCH: mean cell hemoglobin, MCHC: mean cell hemoglobin concentration, PLT: platelet, LYM: lymphocytes.